Literature DB >> 7911558

Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not in the nigrostriatal dopaminergic system.

J L Andersson1, M Marcus, G G Nomikos, T H Svensson.   

Abstract

Most antipsychotic drugs are, in addition to being dopamine (DA) D2 receptor antagonists, also relatively potent alpha 1 adrenoceptor antagonists. Here, we have studied the effects of the selective DA D2 receptor antagonist raclopride, alone and in combination with the selective alpha 1 adrenoceptor antagonist, prazosin, on midbrain DA neurons utilizing extracellular single cell recording techniques. As a reference compound, haloperidol (0.05-1.6 mg/kg, i.v.), a potent antagonist at both DA D2 receptors and alpha 1 adrenoceptors, was included in the electrophysiological part of the study. In addition, in vivo voltammetry was used to measure extracellular DA concentrations in the nucleus accumbens (NAC) and the dorsolateral striatum (STR) in anesthetized, pargyline pretreated rats treated with the above drugs. Raclopride (10-5120 micrograms/kg, i.v.) induced a dose dependent increase in firing rate of DA neurons in the ventral tegmental area (VTA), that was significant already at 10 micrograms/kg, and in the substantia nigra-zone compacta (SN-ZC), that reached significance at 2560 micrograms/kg. Burst firing of DA neurons was also increased in the VTA at 40 micrograms/kg, as well as in the SN-ZC at 640 micrograms/kg. A low dose of raclopride (80 micrograms/kg, cumulated dose) induced a significant increase in extracellular DA concentrations in NAC to 490% and in STR to 220%. A high dose of raclopride (2560 micrograms/kg, cumulated dose) induced a 930% increase in extracellular DA concentrations in NAC, but only a 280% increase in STR. These data demonstrate that raclopride exerts a relatively selective action on mesolimbic DA neurons. Prazosin (0.3 mg/kg, i.v.) decreased burst firing of VTA, but not SN-ZC DA neurons.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911558     DOI: 10.1007/bf00169289

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  43 in total

1.  Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry.

Authors:  F G Gonon
Journal:  Neuroscience       Date:  1988-01       Impact factor: 3.590

2.  Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis.

Authors:  A J Lategan; M R Marien; F C Colpaert
Journal:  Brain Res       Date:  1990-07-16       Impact factor: 3.252

3.  Anatomy of brain alpha 1-adrenergic receptors: in vitro autoradiography with [125I]-heat.

Authors:  L S Jones; L L Gauger; J N Davis
Journal:  J Comp Neurol       Date:  1985-01-08       Impact factor: 3.215

4.  Local cooling of pre-frontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo.

Authors:  T H Svensson; C S Tung
Journal:  Acta Physiol Scand       Date:  1989-05

5.  Collateral sprouting and reduced activity of the rat mesocortical dopaminergic neurons after selective destruction of the ascending noradrenergic bundles.

Authors:  J P Tassin; S Lavielle; D Hervé; G Blanc; A M Thierry; C Alvarez; B Berger; J Glowinski
Journal:  Neuroscience       Date:  1979       Impact factor: 3.590

6.  Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization.

Authors:  A A Grace; B S Bunney
Journal:  Neuroscience       Date:  1983-10       Impact factor: 3.590

7.  Diminished responses of nigral dopaminergic neurons to haloperidol and morphine following lesions in the striatum.

Authors:  Y Kondo; K Iwatsubo
Journal:  Brain Res       Date:  1980-01-06       Impact factor: 3.252

8.  Clonidine modulates dopamine cell firing in rat ventral tegmental area.

Authors:  J Grenhoff; T H Svensson
Journal:  Eur J Pharmacol       Date:  1989-06-08       Impact factor: 4.432

9.  Reduction of dopamine utilization in the prefrontal cortex but not in the nucleus accumbens after selective destruction of noradrenergic fibers innervating the ventral tegmental area in the rat.

Authors:  D Herve; G Blanc; J Glowinski; J P Tassin
Journal:  Brain Res       Date:  1982-04-15       Impact factor: 3.252

10.  On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals.

Authors:  B H Westerink; J B de Vries
Journal:  Neurosci Lett       Date:  1989-04-24       Impact factor: 3.046

View more
  6 in total

1.  Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.

Authors:  A Schotte; P F Janssen; W Gommeren; W H Luyten; P Van Gompel; A S Lesage; K De Loore; J E Leysen
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

Review 2.  Gene expression profiles of brain dopamine neurons and relevance to neuropsychiatric disease.

Authors:  James G Greene
Journal:  J Physiol       Date:  2006-06-01       Impact factor: 5.182

3.  What were they thinking? Cognitive states may influence [11C]raclopride binding potential in the striatum.

Authors:  Karmen K Yoder; David A Kareken; Evan D Morris
Journal:  Neurosci Lett       Date:  2007-12-03       Impact factor: 3.046

4.  Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.

Authors:  J L Andersson; G G Nomikos; M Marcus; P Hertel; J M Mathé; T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000

5.  Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms.

Authors:  Olivia Frånberg; Monica M Marcus; Vladimir Ivanov; Björn Schilström; Mohammed Shahid; Torgny H Svensson
Journal:  Psychopharmacology (Berl)       Date:  2009-02-07       Impact factor: 4.530

6.  Involvement of alpha1-adrenergic receptors in tranylcypromine enhancement of nicotine self-administration in rat.

Authors:  Anne-Sophie Villégier; Shahrdad Lotfipour; James D Belluzzi; Frances M Leslie
Journal:  Psychopharmacology (Berl)       Date:  2007-05-08       Impact factor: 4.415

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.